Alcatel-Lucent SA Rating Reiterated by Credit Suisse (ALU)

Alcatel-Lucent SA (EPA: ALU)‘s stock had its “neutral” rating reiterated by investment analysts at Credit Suisse in a note issued to investors on Wednesday, Stock Ratings Network.com reports. They currently have a €1.25 ($1.62) price target on the stock.

Shares of Alcatel-Lucent SA (EPA: ALU) traded up 0.29% during mid-day trading on Wednesday, hitting €1.364. Alcatel-Lucent SA has a 52 week low of €0.71 and a 52 week high of €1.438. The stock’s 50-day moving average is currently €0.89. The company’s market cap is €3.098 billion.

ALU has been the subject of a number of other recent research reports. Analysts at Berenberg Bank reiterated a “sell” rating on shares of Alcatel-Lucent SA in a research note to investors on Wednesday, June 5th. They now have a €0.70 ($0.91) price target on the stock. Separately, analysts at Societe Generale reiterated a “sell” rating on shares of Alcatel-Lucent SA in a research note to investors on Tuesday, May 28th. They now have a €0.65 ($0.84) price target on the stock. Finally, analysts at AlphaValue reiterated a “buy” rating on shares of Alcatel-Lucent SA in a research note to investors on Thursday, May 16th. They now have a €2.27 ($2.95) price target on the stock.

Five equities research analysts have rated the stock with a sell rating, six have assigned a hold rating and one has assigned a buy rating to the company’s stock. Alcatel-Lucent SA presently has an average rating of “Hold” and an average target price of €1.02 ($1.32).

Alcatel Lucent SA is a France based company that proposes solutions used by service providers, businesses, and governments worldwide to offer voice, data, and video services to their own customers.

Latest News

Atkore International Group Inc  Receives Consensus Rating of “Buy” from Brokerages
Atkore International Group Inc Receives Consensus Rating of “Buy” from Brokerages
Brokerages Expect Sprint Corp  to Announce $0.01 Earnings Per Share
Brokerages Expect Sprint Corp to Announce $0.01 Earnings Per Share
CymaBay Therapeutics Inc  Receives $19.00 Average Price Target from Analysts
CymaBay Therapeutics Inc Receives $19.00 Average Price Target from Analysts
Zonecoin Achieves Market Capitalization of $25,297.00
Zonecoin Achieves Market Capitalization of $25,297.00
Boolberry Price Reaches $0.84
Boolberry Price Reaches $0.84
EZToken Price Reaches $0.36
EZToken Price Reaches $0.36


© 2006-2018 Ticker Report. Google+.